1089- Phase 3 double-blind study of F/TAF in HIV-1 positive patients

• Research type

  Research Study

• Full title

  A Phase 3, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV 1 Positive Subjects who are Virologically Suppressed on Regimens containing FTC/TDF

• IRAS ID

  147356

• Contact name

  Graeme Moyle

• Contact email

  Graeme.Moyle@chelwest.nhs.uk

• Sponsor organisation

  Gilead Sciences, Inc.

• Eudract number

  2013-005138-39

• ISRCTN Number

  n/a

• REC name

  South Central - Hampshire B Research Ethics Committee

• REC reference

  14/SC/0225

• Date of REC Opinion

  16 May 2014

• REC opinion

  Further Information Favourable Opinion